The two dividend-paying generic pharmaceutical stocks to buy are especially appealing because they can produce further growth organically and through acquisitions. One trade-off is that the two dividend-paying generic pharmaceutical stocks lack the blockbuster potential of companies that launch promising new drugs aimed at huge potential markets that could cause their share prices to soar.
Among India’s top generic drug stocks for investors are Dr. Reddy’s Laboratories (NYSE:RDY), Sun Pharmaceutical industries (524715.India), Divi’s Laboratories (532488.India) and Cipla (500087.India). However, the generic sector of the pharmaceutical industry has had problems, Carlson cautioned. Investors focused on income probably are better off buying into a big pharmaceutical manufacturer like Viatris Inc. (NASDAQ:VTRS), a Canonsburg, Pennsylvania-based specialty and generics drug company that was formed by a merger between Pfizer’s (NYSE: PFE) Upjohn legacy brands business and Mylan, a generic and biosimilar drug manufacturer, Kramer said. Viatris has a “commanding franchise” and pays a 3% dividend as a bonus, Kramer counseled. One pure play I’d recommend right now: Amneal Pharmaceuticals Inc. (NYSE:AMRX), which shot into the market spotlight with generic epinephrine pens,” Kramer said.
Source: DividendInvestor
Related Articles:
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.